{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Breast+Neoplasms&page=45", "query": { "condition": "Breast Neoplasms", "page": 45 }, "page_size": 10 }, "pagination": { "page": 45, "page_size": 10, "total_count": 7077, "total_pages": 708, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Breast+Neoplasms&page=46&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Breast+Neoplasms&page=44&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-29T00:43:28.505Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00043394", "title": "CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Carcinoma, Breast" ], "interventions": [ { "name": "0.04 mg/kg CpG 7909", "type": "DRUG" }, { "name": "Herceptin®", "type": "DRUG" }, { "name": "0.08 mg/kg CpG 7909", "type": "DRUG" }, { "name": "0.12 mg/kg CpG 7909", "type": "DRUG" }, { "name": "0.16 mg/kg CpG 7909", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 16, "start_date": "2002-09", "completion_date": "2003-10", "has_results": false, "last_update_posted_date": "2009-03-12", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 12, "location_summary": "Berkely, California • Orange, California • Palm Springs, California + 9 more", "locations": [ { "city": "Berkely", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00043394" }, { "nct_id": "NCT06879522", "title": "Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer Survivor", "Cancer Related Fatigue" ], "interventions": [ { "name": "Maximizing Energy Intervention", "type": "BEHAVIORAL" }, { "name": "Health Education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 15, "start_date": "2025-05-14", "completion_date": "2026-02-02", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06879522" }, { "nct_id": "NCT00749931", "title": "MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "MarginProbe", "type": "DEVICE" }, { "name": "Lumpectomy", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "Dune Medical Devices", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "FEMALE", "summary": "18 Years to 90 Years · Female only" }, "enrollment_count": 664, "start_date": "2008-10", "completion_date": "2010-06", "has_results": true, "last_update_posted_date": "2014-06-27", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 18, "location_summary": "Costa Mesa, California • Los Angeles, California • Newport Beach, California + 8 more", "locations": [ { "city": "Costa Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00749931" }, { "nct_id": "NCT05598879", "title": "Global Cardio Oncology Registry", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Hematologic Malignancy", "Immune Checkpoint Inhibitor-Related Myocarditis", "Cardiotoxicity", "Cardiovascular Diseases" ], "interventions": [ { "name": "anonymized data collection during programmed surveillance clinical follow up", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5000, "start_date": "2022-07-01", "completion_date": "2029-07-01", "has_results": false, "last_update_posted_date": "2026-05-12", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 1, "location_summary": "Weston, Florida", "locations": [ { "city": "Weston", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05598879" }, { "nct_id": "NCT00114296", "title": "Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "omega-3 fatty acid", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 80, "start_date": "2005-04", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-09-17", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00114296" }, { "nct_id": "NCT00003086", "title": "Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "CAF regimen", "type": "DRUG" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "cisplatin", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "doxorubicin hydrochloride", "type": "DRUG" }, { "name": "fluorouracil", "type": "DRUG" }, { "name": "ifosfamide", "type": "DRUG" }, { "name": "melphalan", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" }, { "name": "thiotepa", "type": "DRUG" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "samarium Sm 153 lexidronam pentasodium", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Louisiana State University Health Sciences Center Shreveport", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "21 Years to 65 Years · Female only" }, "enrollment_count": 12, "start_date": "1997-03", "completion_date": "2001-01-28", "has_results": false, "last_update_posted_date": "2020-07-14", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 1, "location_summary": "Shreveport, Louisiana", "locations": [ { "city": "Shreveport", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003086" }, { "nct_id": "NCT00898703", "title": "Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "flow cytometry", "type": "OTHER" }, { "name": "immunoenzyme technique", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 50, "start_date": "2001-08", "completion_date": "2007-03", "has_results": false, "last_update_posted_date": "2012-12-17", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00898703" }, { "nct_id": "NCT00337103", "title": "E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Metastatic Breast Cancer" ], "interventions": [ { "name": "Eribulin Mesylate", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1276, "start_date": "2006-09-20", "completion_date": "2017-12-11", "has_results": true, "last_update_posted_date": "2020-06-18", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 13, "location_summary": "Anaheim, California • La Verne, California • Poway, California + 10 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "La Verne", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "Centralia", "state": "Illinois" }, { "city": "Augusta", "state": "Maine" } ], "official_url": "https://clinicaltrials.gov/study/NCT00337103" }, { "nct_id": "NCT00338286", "title": "A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Breast Cancer", "Neoplasm Metastasis" ], "interventions": [ { "name": "Standard supportive care (packed RBC transfusion)", "type": "OTHER" }, { "name": "epoetin alfa + packed RBC transfusion", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "FEMALE", "summary": "18 Years to 99 Years · Female only" }, "enrollment_count": 2098, "start_date": "2006-03-02", "completion_date": "2017-01-31", "has_results": true, "last_update_posted_date": "2018-03-19", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 14, "location_summary": "Anaheim, California • Gainesville, Florida • Miami, Florida + 11 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "New Port Richey", "state": "Florida" }, { "city": "Rockledge", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00338286" }, { "nct_id": "NCT01875666", "title": "Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Breast Neoplasms" ], "interventions": [ { "name": "Trastuzumab", "type": "DRUG" }, { "name": "pertuzumab", "type": "DRUG" }, { "name": "lapatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UNC Lineberger Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 26, "start_date": "2013-08-05", "completion_date": "2016-12-19", "has_results": false, "last_update_posted_date": "2020-09-04", "last_synced_at": "2026-10-29T00:43:28.505Z", "location_count": 5, "location_summary": "Birmingham, Alabama • Indianapolis, Indiana • Boston, Massachusetts + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01875666" } ] }